Skip to main content

Table 3 Statistically unique protein families in Cipangopaludina cahayensis and Pomacea canaliculata

From: Transcriptome analysis between invasive Pomacea canaliculata and indigenous Cipangopaludina cahayensis reveals genomic divergence and diagnostic microsatellite/SSR markers

KO term

No. of DEGs*

No. of genes**

p-value

Pathway

Cipangopaludina cahayensis

  

ko05145

87 (6.21%)

316 (2.37%)

8.262866e-18

toxoplasmosis

ko04210

71 (5.06%)

251 (1.88%)

2.041735e-15

apoptosis

ko05222

64 (4.56%)

264 (1.98%)

8.751653e-11

small cell lung cancer

ko05144

23 (1.64%)

55 (0.41%)

1.741389e-09

malaria

ko04621

47 (3.35%)

190 (1.42%)

1.417618e-08

NOD-like receptor signaling pathway

ko05014

29 (2.07%)

102 (0.76%)

3.722068e-07

amyotrophic lateral sclerosis (ALS)

ko05200

97 (6.92%)

577 (4.32%)

1.527724e-06

pathways in cancer

ko05146

39 (2.78%)

170 (1.27%)

1.852183e-06

amoebiasis

ko00590

29 (2.07%)

119 (0.89%)

1.106722e-05

arachidonic acid metabolism

ko05416

35 (2.5%)

158 (1.18%)

1.392634e-05

viral myocarditis

ko05210

27 (1.93%)

116 (0.87%)

5.248618e-05

colorectal cancer

ko05323

20 (1.43%)

76 (0.57%)

7.901248e-05

rheumatoid arthritis

Pomacea canaliculata

   

ko00940

22 (1.05%)

23 (0.17%)

1.61937e-17

Phenylpropanoid biosynthesis

ko04977

71 (3.4%)

172 (1.25%)

7.427869e-17

vitamin digestion and absorption

ko00140

52 (2.49%)

120 (0.87%)

1.004048e-13

Steroid hormone biosynthesis

ko04512

57 (2.73%)

158 (1.14%)

5.811497e-11

ECM-receptor interaction

ko00830

49 (2.35%)

126 (0.91%)

6.057395e-11

Retinol metabolism

ko00980

49 (2.35%)

129 (0.93%)

1.610139e-10

Metabolism of xenobiotics by cytochrome P450

ko00130

24 (1.15%)

41 (0.3%)

2.008634e-10

Ubiquinone and other terpenoid-quinone biosynthesis

ko00591

45 (2.15%)

116 (0.84%)

4.002728e-10

linoleic acid metabolism

ko00533

22 (1.05%)

38 (0.28%)

1.543998e-09

glycosaminoglycan biosynthesis - keratan sulfate

ko00740

21 (1.01%)

37 (0.27%)

5.989671e-09

riboflavin metabolism

ko00360

26 (1.24%)

54 (0.39%)

1.007722e-08

Phenylalanine metabolism

ko00982

47 (2.25%)

142 (1.03%)

6.201926e-08

drug metabolism-cytochrome P450

ko00627

41 (1.96%)

119 (0.86%)

1.229762e-07

aminobenzoate degradation

ko04142

84 (4.02%)

321 (2.32%)

1.553304e-07

lysosome

ko00590

45 (2.15%)

138 (1%)

1.921892e-07

arachidonic acid metabolism

ko00983

47 (2.25%)

147 (1.06%)

2.012819e-07

drug metabolism-other enzymes

ko02020

16 (0.77%)

31 (0.22%)

2.208469e-06

two-component system

  1. *The number of differentially expressed genes (DEGs) that belong to a KEGG pathway.
  2. **The total number of orthologous genes that belong to a KEGG pathway.